Frontlight ResearchEarly access
Not yet taking people in United StatesNo phase
Adaptive Radiotherapy for Patients With GBM
Key facts
- Who runs it
- Abramson Cancer Center at Penn Medicine
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 20 people, planned
- Starts
- Jan 2027
- Expected to end
- Sept 2030
- Type of study
- Interventional
- Treatments tested
- MRI-Guided Adaptive Radiation Therapy
- Record updated
- 12 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Histologically confirmed IDH-wildtype glioblastoma (WHO Grade 4)
- Age ≥ 18 years
- Karnofsky Performance Status ≥ 60
- Planned 30 or 15 fractions of radiation therapy with or without concurrent systemic therapy
- Ability to undergo MRI imaging with IV gadolinium contrast
- Ability to provide written informed consent
- Multifocal tumors permitted if clinician anticipates they will be encompassed in a single radiation plan
Who cannot take part
- Prior intracranial radiotherapy
- Multicentric disease
- Leptomeningeal dissemination
- Pregnancy
Where in United States
- University of PennsylvaniaPhiladelphia, United StatesContact: Marlowe EstiokoNot yet recruiting
About the trial
What the trial wants to find out
This is a single institution single arm feasibility study of MRI-guided, personalized adaptive radiation therapy with reduced margins for patients with glioblastoma.
The group in the trial
- MRI-Guided Adaptive Radiation TherapyTreatment being tested
The study intervention is MRI-guided adaptive radiation therapy with reduced treatment margins among patients with glioblastoma.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- ART-GBM: Feasibility Study of Adaptive Radiotherapy (ART) for Patients With Glioblastoma (GBM)
- Record updated
- 12 November 2026